Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 561-570 Newer>

CIO August 1, 2002 Stephanie Overby	Rx for Chicken Scratch Poor physician penmanship is the butt of many jokes, but illegible prescriptions are no laughing matter. Some pharmacies are starting to use electronic systems to accept prescriptions from doctors electronically via PC, PDA, or cell phone, thus ensuring accurate prescription filling.
IndustryWeek August 1, 2002 Tonya Vinas	Locations -- R.I. Plants To Supply Key Drug Immunex Corp. chooses West Greenwich for BioNext Project, which will produce Enbrel and other drugs for the growing biotech company.
IndustryWeek August 1, 2002 Doug Bartholomew	Health Care's Shocking Affliction This trillion-dollar industry is shamefully backward when it comes to IT.
Knowledge@Wharton	Bristol-Myers Squibb Illustrates Woes of Ailing Pharmaceutical Industry The once-mighty pharmaceutical industry, for years the nation's most profitable, has begun to show some cracks. But no major U.S. drug maker seems to be facing more problems than Bristol-Myers Squibb.
Bio-IT World July 11, 2002 Judith N. Mottl	Learning to Love Linux Hungry for computing power, life science companies are turning toward Linux clusters as the preferred high performance solution.
Bio-IT World July 11, 2002 Salvatore Salamone	P2P's Powerful Promise Systems management remains difficult, but the payoff is getting teraflop computing from a sea of commodity PCs. Just ask Entelos and Novartis.
Bio-IT World July 11, 2002 Malorye Branca	Deep Sequence Diving Like sailors of old, genomic data miners dream of discovering riches and fame. Given the recent improvements in analytics -- and a little more time -- they just might succeed.
Bio-IT World July 11, 2002 Curtis Franklin Jr.	Source of Debate Open source software is gaining popularity at biotech companies, but thorny issues, such as intellectual property, remain. Do the benefits outweigh the risks?
Bio-IT World July 11, 2002 Mark D. Uehling	Flirting with Genomic Disaster A conversation with political scientist Francis Fukuyama about the prospect of ethics regulation in biotechnology.
Bio-IT World July 11, 2002 Stephen T.C. Wong	Neuro-IT Needs Integrated Infrastructure There are two major motivations for merging enterprise solutions into clinical neuroscience. The first is the need to scale up the capacity for data management. The second is the economic benefits of data sharing, software reuse, and infrastructure build-out while reducing costs.
<Older 561-570 Newer> Return to current articles.